Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
A stinking RAT = someone who ramps up the company and secretly trades, causing your money to go down.
A good person = someone who TELLS YOU WHEN TO BUY AND WHEN TO SELL (like I clearly did), causing your money to go up.
I did this for my own amusement the last few weeks to see if anyone on here would listen, or would criticise.
If anyone listened, congrats, you made a decent bit of wedge. But like dunk and others, I knew most wouldn’t. Most people are like ‘detective aim’ looking for secret clues about the company that is going to suddenly reach the moon.
Oh well, it’s make or break time tomorrow at the ATS.
I hope we have something newsworthy, but if we don’t, that is the end of Synairgen and also the end social lives of lots of people on here.
Good luck all, make or break time ahead :)
Pre market speculation. What’s it gonna be, the beginning of a new venture for Synairgen, or the end of the road for the company?
At least tomorrow is definitive, we either find out that there is scope to this company still to come, or that it’s going to be the end of the road.
GLTA.
dunk, didn’t you see my olive branch?
I held out an olive branch AND then I told everyone to trade the stock. I told them what days to SELL and what days to BUY.
If you (or anyone else) had done what I said then you would have made 30% profit.
It is actually hilarious, the whole lot of you are totally hilarious, we sit on the eve of the potential BEGINNING OR END of this company and you still don’t listen to me, when you could’ve made thousands :D :D
What’s hilarious is that I spelt it out plain and simple, I told you the trading pattern was exactly the same as per sprinter and told you when to buy and sell.
Instead of making money, there are people on this forum (completely sad as f11k people with absolutely zero social lives and nothing going for them) who instead of taking trading advice and make money for themselves, would rather say ‘Raaaah, andybe4 you said this bla blah’. You utter naive fools, I told you all when to buy and when to sell, everything I told you has come true, but you still wouldn’t even listen.
This board should be about HELPING EACH OTHER MAKE MONEY. Perhaps if people listened, they might end up making money and leading a better social life.
Anyway, it’s make or break time tomorrow for you dunk and for everyone else (including me) on this forum. Synairgen either show something good (let’s hope), or it is GAME OVER for the company.
What’s it gonna be dunk? Celebrations or curtains?
Here it comes ;)
Well done manifesto, you’ve held the torch for Synairgen the whole time. Tomorrow is CRUNCH TIME. It’s time for the company to step up and show data and a route to commercial success, surrounded by their peers and big pharma with large wallets.
We are all due some good news.
At least the only consolation if we get bad news = it’s over, the company is finished and we can completely forget about Synairgen for the rest of our lives. But come on, if ever there was a day where this company MUST release some good news it will be on Monday.
Thanks Palladin, I was correct indeed.
I’ve made a tad under 30% extra shares over the last few weeks now. I also tried to help (and hopefully did help) some people on this forum. It was very simple, the trading pattern exactly the same as re sprinter. So it was obvious that the SP would plummet every Monday that there was no RNS.
Anyway, I’m 100% back in and taking the punt on the ATS. We could all end up being burnt yet again by this company.
I’ve said before and will say again, this ATS is MAKE OR BREAK time for the company, they either produce some decent data and some news or it’s curtains.
No amount of ramping or development/mutation of covid or science about interferons can flog a dead drug to market. If this company can not produce anything newsworthy, given they have spent 25 million and had 6 months analysing it, then they’re totally useless.
Tomorrow is our last chance, let’s hope we finally get rewarded for staying with this company. Or I suppose the very worst is that we finally find out the stone cold truth that they are just a bunch a research students that have no ability for commercial success at all. One way or another it ends this coming week.
Congrats to those who traded, or took the advice re the trading pattern that I mentioned over the last two weeks. That’s what this forum should be about, helping each other to make profit. We have all been badly burnt by the company on the 21st, so if we use each other’s knowledge to help make each other profit, that’s how these types of forum can be of good use.
To those who listened to me and made 25% over the last two weeks, I can not give any advice on what’s coming tomorrow I’m afraid.
Myself and most other holders on here were very badly burnt by the calamity of the 21st. But I have decided to stay with the company, given that they have announced via RNS that they are presenting the deep dive data at the conference. I’m going for the punt.
If you also decide to go for the punt tomorrow, let’s hope we finally get some well deserved news.
GLTA, it’s either celebrations or curtains for the company,
Dudio, actually I’m not.
Like others on here, I’m going in for the punt on Monday.
This company has promised so much and delivered tuppence so far. So it’s about time luck changed.
For me it’s worth the punt. But you must decide what’s best for you.
Btw, if you sold on Monday first thing and bought back in, congrats to you too for making profit.
That’s what this forum should be about, helping each other make money ;)
As per the title.
I wrote a post on Sunday evening explaining that the trading pattern was exactly the same as pre SPRINTER readout.
I could only sell £3k of shares (wouldn’t let me sell me), but bought back on Monday.
If you followed the advice and did the same, well done, you’ve got your 10% back, as I promised.
As predicted the SP is increasing again today. Hopefully 27p will be breached later.
Feel free to sell now and collect that extra 10% profit, or keep your money in for the punt on this company for next weeks ATS conference presentations.
I’m keeping my money in, as it’s worth the punt.
But please be aware that with Synairgen, absolutely anything goes. There is certainly no guarantee of success, but they specifically RNS’d that they will be presenting deep dive data next week AND they tweeted it as well. Only the most useless of fools would RNS and tweet it only to then either not release any new data or release terrible new data, it would be a total mockery to the company, to Sir Stephen Holgate and a total embarrassment in front of the whole pharma world for them. So I have faith that this time they will announce something positive.
Well done to those who did the same as me, the trade and the 10% profit, now I’m going to take the punt on Mondays conference.
All the best everyone, have a fab weekend, enjoy the sunshine. Time for Margs at the Ned with the boss for me and a slap up weekend in sunny Chelmsford.
GLTA. Xxxx
Lima, read my posts the last couple of weeks.
Didn’t you see me call the trading patterns and the price drops, helping people when to buy and sell?
You seem to have a selective reading ability/memory ;)
Now, look back at my post where I told people to sell on Monday (due to no RNS) and that they would gain at least 10% by the week end.
Read it and weep boy. Hahahaha ;)
I was right again.
Tbh, it’s immaterial. I believe 27p will be breached today, but in order to get this stock back on the road again we need the company to announce something positive next week.
This stock is going to explode on Monday after the ATS conference when Synairgen announce their deep dive data.
We know they are announcing it because:
1. They RNS’d that they are announcing it, in their last RNS.
2. They tweeted that they are announcing it.
There must be some good info in the data they are going to present, afterall not even the most incompetent of idiots would announce they were presenting their data and then present horrendous data. They would simply just not turn up at the ATS, sparing themselves the embarrassment of presenting rubbish data.
They’ve got something and they are saving it for this conference because the big boys of the pharma world are going to be there.
It’s the last chance saloon for Synairgen next week, YOU DON’T WANT to be out of this one.
It’s make or break time for the company, when they present their data it can put the drug back on the road to commercialisation again, or it can reaffirm that it’s a dud and kill the whole project.
The evidence (from Synairgen themselves) looks very hopeful.
So it’s the last chance to buy in today at these silly cheap prices. Synairgen knows SNG001 interferon beta is the future of fighting respiratory illnesses, so they’re saving their good data for the ATS.
Burstead, why is it doomed?
Why on earth would they present data at the conference if they know that the data is a pile of rubbish?
They would certainly not RNS that they are presenting the deep dive data and then go to the ATS conference and present a failing pile of garbage to the audience, they would be a total laughing stock in front of all their peers and all the big players in pharma.
They must have something. They can’t possibly go to the conference and present old P2 data from July 2020 when they have told the markets that they are going to be presenting deep dive data.
There must be something worthwhile presenting in the deep dive data, otherwise they are just going to embarrass themselves.
We know why it’s taken this long. It’s Synairgen. They take forever to do anything. We’ve known this for the last two years, except only now are people actually being honest and calling it out.
I was calling them out pre SPRINTER call out for months, ‘the tortoise’. Only our tortoise never turned in to a rocket, it turned in to a slug.
Let’s hope this slug can turn in to something slightly more appealing, maybe a frog or a chicken or something. If we get 60p it’ll be a freakin miracle.
Palladin, you could be very nicely surprised next week.
50/60p will be reached if Synairgen announce an interesting development.
I think we will be above 27p on Friday. If there is very good data to present next week, our SP could rise 200%, especially if the long covid data is good, then it will certainly alert big pharma.
Even with a decent data set announced we should see a rise in SP over the next few months until some concrete news of developments can happen, either a new trial or JV etc.
My fear is that nothing particularly interesting is revealed at this conference, the reason for this fear = we haven’t had an RNS yet. I thought that we would get an RNS regarding market sensitive information, ie some really good discovery within the deep dive data, but we haven’t. Does this mean there is nothing interesting, or does it mean that Synairgen are waiting until the conference, I don’t know.
If something good is announced, we should get that 50p again. If it’s very mediocre and hashing over old ground then we drift down to 16/18p and then we rely solely on the ACTIV2 data for any price increase.
That’s what my instinct is telling me. Damn, we are due some good news for a change, surely this company can find something in the 6 months after analysis started on the data from a £20 million trial to announce to the conference?
I have to admit, I still believe the SP will rise to 27p on Friday. But surprised that it hasn’t already started to rise yet.
Do you think that the market is pessimistic about the prospect of any decent data from Synairgen based on the fact they haven’t RNS’d anything yet?
The article written about them, whilst accurate, was also not taking in to consideration the upcoming conference that they have stated they will ‘reveal results and data at’. Perhaps after the line of bad news in recent months the market is taking a reactionary behaviour for this share, as opposed to proactively wanted to invest before news.
We’ve had a horrendous few months, so come on Dickie Marsden, show us why you’re the CEO and let’s announce something positive at the conference to get SNG001 back on the route to commercialisation again.
Good time to invest now. 26.5p will be breached on Friday, more and more people buying in for a punt at the conference next week.
There’s 10% profit margin in 3 days coming up.
Alternatively take a punt and leave your money in to see what happens at the conference.
Seems like a relatively accurate article, she says that everything lies on the ACTIV2 P2 results and the SPRINTER data.
However she doesn’t mention that the SPRINTER data has been scheduled (by Synairgen via RNS) to be shown at the thoracic conference next week.
It’s the same as I called it a few days ago.
It’s make or break time for the company at this conference. They either reveal something decent from SPRINTER deep dive, or they reveal ACTIV2 results.
If these things fail to deliver, then it will be curtains for the foreseeable.
But if the company delivers something from the deep dive or ACTIV2 then we might be able to salvage SNG001 and be back on a path towards approval and commercialisation.
Make or break time at the conference next week.
Well said Manifesto, quite rightly pointing out. Synairgen were invited to speak by an exclusive panel.
Time to buy back in, or invest in this company for the first time for an educated punt before next weeks conference.
Obviously no guarantees, but Synairgen themselves RNS’d that they would be announcing data at this conference. Nobody would RNS this and then have nothing to present.
Particularly after the SP drop today, it now represents a good price to buy in.
Agree, it’s make or break time for Synairgen.
If you were fortunate to take the trade this morning and buy back in 10% cheaper, well done.
Or if you are currently out and want to take the punt on this company before the conference.
Either way, now is the time to get back in to this stock.
Next week we will learn what Synairgen have discovered from the deep analysis of the SPRINTER trial. After lots of pain three months ago, it’s crunch time again for the company and investors.
Hopefully we will get some long due good news :)
Palladin, thanks. I agree with your post.
My trading is now complete, I’m ‘all in’ again. But let’s wait and see what happens next week. I’m hoping for some good news that will elevate the SP and help all of us. However I’m also aware that things might not go as hoped and could be curtains (for covid) for the company. We’ve been burnt once, we might get burnt again. Our faith in Synairgen comes from our faith in Interferon beta as a therapeutic, unfortunately not in the company itself.
Investing in Synairgen is not the same as investing in a solid, reliable and professional company who are developing an interferon beta drug. We have all learnt this the hard way. But given the fact they’ve now had a further 12 weeks to analyse the data and they also RNS’d that they will be presenting findings at the conference, one would like to think that they have something positive to announce.
Make or break time next week, GLA.
It’s actually quite funny looking at some of the responses I get when I’ve helped people trade and potentially make money.
You mad you didn’t listen now andrew? Haha just utterly hilarious.
Anyway, let’s see, if Synairgen have good findings to present at the conference next week the SP should make a nice rise.
But remember, if the findings are not good or non existent, that is THE END for this company for a few years. So all the ramping on here, all the science saying is good interferons are = all totally meaningless because this company will have zero chance of becoming commercial. It ALL hinges on what is presented at this conference.
I for one hope that there is good news released at the conference next week and despite all the pathetic squabbling from the usual members on here, hopefully we can all start to have an increase in our investment from next week.
Well done to those who took the trade.
GLA.